MedTrace Logo

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Relationship Between Intraoperative Intravenous Acetaminophen and Postoperative Opioid Avoidance for Ambulatory Surgical Procedures

NCT01231191 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2012-03-08

No results posted yet for this study

Summary

This is a research study to determine if giving acetaminophen intravenously in hte operating room will decrease the number of patients who require additional pain medicine, such as morphine, after surgery in the recovery room.

Conditions

  • Postoperative Pain
  • Intraoperative and Postoperative Opioid Requirements

Interventions

DRUG

Intravenous acetaminophen

Acetaminophen 1000 mg administered over 15 minutes intravenously as soon as feasible intraoperatively.

DRUG

Intravenous placebo

Normal saline administered over 15 minutes intravenously as soon as feasible intraoperatively.

Sponsors & Collaborators

Principal Investigators

  • Brian M Ilfeld, M.D., M.S. · University of California, San Diego

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01231191 on ClinicalTrials.gov